Immutep IMMP
NASDAQ IMMP
$0.39 0.00 (-1.28%)
At close: Aug 21, 2026 · 4:00 PM EDT

Immutep (IMMP) Net Shares Issued and Repurchased (2011 - 2025)

Immutep's (IMMP) quarterly Net Shares Issued and Repurchased came in at $359.6 million in Q4 2025, up 1.25% YoY from $355.1 million in Q4 2024, and up 3.07% on a QoQ basis from $348.9 million in Q2 2025.

Immutep (IMMP) Net Shares Issued and Repurchased (2011 - 2025) Analysis & Trends

Immutep (IMMP) has 15 years of Net Shares Issued and Repurchased data on file, last reported at $359.6 million in Q4 2025.

  • Quarterly Net Shares Issued and Repurchased rose 1.25% year-over-year to $359.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $359.6 million (up 1.25% YoY) and the FY2025 annual result came in at $348.9 million, down 2.35% from the prior year.
  • Net Shares Issued and Repurchased advanced to $359.6 million in Q4 2025, from $348.9 million in the prior quarter.
  • In the past five years, Net Shares Issued and Repurchased ranged from a high of $359.6 million in Q4 2025 to a low of $241.4 million in Q2 2021.
  • A 5-year average of $302.4 million and a median of $294.5 million in 2023 frame the typical range for Net Shares Issued and Repurchased.
  • Annual changes were most pronounced in 2021 — Net Shares Issued and Repurchased soared 51.55% — and 2022, when it dropped 8.58%.
  • Tracing IMMP's Net Shares Issued and Repurchased over 5 years: stood at $266.2 million in 2021, then fell by 8.58% to $243.3 million in 2022, then advanced by 19.52% to $290.8 million in 2023, then rose by 22.12% to $355.1 million in 2024, then gained by 1.25% to $359.6 million in 2025.
  • The last three Net Shares Issued and Repurchased figures came in at $359.6 million (Q4 2025), $348.9 million (Q2 2025), and $355.1 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Immutep 56.46 Mn -8.63 Mn - 359.58 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 359.58 Mn
Dec 31, 2025 359.58 Mn
Jun 30, 2025 348.86 Mn
Jun 30, 2025 348.86 Mn
Dec 31, 2024 355.14 Mn
Dec 31, 2024 355.14 Mn
Jun 30, 2024 357.26 Mn
Jun 30, 2024 357.26 Mn
Dec 31, 2023 290.80 Mn
Dec 31, 2023 290.80 Mn
Jun 30, 2023 298.27 Mn
Jun 30, 2023 298.27 Mn
Dec 31, 2022 243.32 Mn
Dec 31, 2022 243.32 Mn
Jun 30, 2022 263.16 Mn
Jun 30, 2022 263.16 Mn
Dec 31, 2021 266.16 Mn
Dec 31, 2021 266.16 Mn
Jun 30, 2021 241.35 Mn
Jun 30, 2021 241.35 Mn